ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sterile Infusions Compounding Pharmacy Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-7T11200
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Sterile Infusions Compounding Pharmacy Market Research Report 2022
BUY CHAPTERS

Global Sterile Infusions Compounding Pharmacy Market Research Report 2025

Code: QYRE-Auto-7T11200
Report
February 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Baxter
B. Braun
Fresenius Kabi
Kelun Pharma
Otsuka Pharmaceutical
JW Pharmaceutical
Pfizer Inc
Teva Pharmaceutical
Haisco Pharmaceutical Group
King York
Cisen
Lummy
Grand Life Sciences
Medisan
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi'an Libang Pharmaceutical
Lionco Pharmaceutical
China Meheco Kangli

Sterile Infusions Compounding Pharmacy Market Size

The global market for Sterile Infusions Compounding Pharmacy was valued at US$ 2760 million in the year 2024 and is projected to reach a revised size of US$ 3207 million by 2031, growing at a CAGR of 2.2% during the forecast period.

Sterile Infusions Compounding Pharmacy Market

Sterile Infusions Compounding Pharmacy Market

There’s a higher risk of infection or serious problems if contaminants get into the medication. So, sterile compounds are made in a special environment with additional requirements to minimize this risk. 
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sterile Infusions Compounding Pharmacy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile Infusions Compounding Pharmacy.
The Sterile Infusions Compounding Pharmacy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sterile Infusions Compounding Pharmacy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sterile Infusions Compounding Pharmacy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Sterile Infusions Compounding Pharmacy Market Report

Report Metric Details
Report Name Sterile Infusions Compounding Pharmacy Market
Accounted market size in year US$ 2760 million
Forecasted market size in 2031 US$ 3207 million
CAGR 2.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Consumers Aged 18 and Younger
  • Consumers Aged 19 to 44
  • Consumers Aged 45 to 64
  • Consumers Aged 65 and Older
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Baxter, B. Braun, Fresenius Kabi, Kelun Pharma, Otsuka Pharmaceutical, JW Pharmaceutical, Pfizer, Teva Pharmaceutical, Haisco Pharmaceutical Group, King York, Cisen, Lummy, Grand Life Sciences, Medisan, BBCA Pharmaceutical, Biokin Pharmaceutical, Xi'an Libang Pharmaceutical, Lionco Pharmaceutical, China Meheco Kangli
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Sterile Infusions Compounding Pharmacy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Sterile Infusions Compounding Pharmacy Market growing?

Ans: The Sterile Infusions Compounding Pharmacy Market witnessing a CAGR of 2.2% during the forecast period 2025-2031.

What is the Sterile Infusions Compounding Pharmacy Market size in 2031?

Ans: The Sterile Infusions Compounding Pharmacy Market size in 2031 will be US$ 3207 million.

Who are the main players in the Sterile Infusions Compounding Pharmacy Market report?

Ans: The main players in the Sterile Infusions Compounding Pharmacy Market are Baxter, B. Braun, Fresenius Kabi, Kelun Pharma, Otsuka Pharmaceutical, JW Pharmaceutical, Pfizer, Teva Pharmaceutical, Haisco Pharmaceutical Group, King York, Cisen, Lummy, Grand Life Sciences, Medisan, BBCA Pharmaceutical, Biokin Pharmaceutical, Xi'an Libang Pharmaceutical, Lionco Pharmaceutical, China Meheco Kangli

What are the Application segmentation covered in the Sterile Infusions Compounding Pharmacy Market report?

Ans: The Applications covered in the Sterile Infusions Compounding Pharmacy Market report are Consumers Aged 18 and Younger, Consumers Aged 19 to 44, Consumers Aged 45 to 64, Consumers Aged 65 and Older

What are the Type segmentation covered in the Sterile Infusions Compounding Pharmacy Market report?

Ans: The Types covered in the Sterile Infusions Compounding Pharmacy Market report are Anti-infectives, Blood Factors, Immunotherapies, Others

Recommended Reports

Sterile Infusion Therapy

Pharmacy & Compounding

Pharmaceutical Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sterile Infusions Compounding Pharmacy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Anti-infectives
1.2.3 Blood Factors
1.2.4 Immunotherapies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Sterile Infusions Compounding Pharmacy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Consumers Aged 18 and Younger
1.3.3 Consumers Aged 19 to 44
1.3.4 Consumers Aged 45 to 64
1.3.5 Consumers Aged 65 and Older
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sterile Infusions Compounding Pharmacy Market Perspective (2020-2031)
2.2 Global Sterile Infusions Compounding Pharmacy Growth Trends by Region
2.2.1 Global Sterile Infusions Compounding Pharmacy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sterile Infusions Compounding Pharmacy Historic Market Size by Region (2020-2025)
2.2.3 Sterile Infusions Compounding Pharmacy Forecasted Market Size by Region (2026-2031)
2.3 Sterile Infusions Compounding Pharmacy Market Dynamics
2.3.1 Sterile Infusions Compounding Pharmacy Industry Trends
2.3.2 Sterile Infusions Compounding Pharmacy Market Drivers
2.3.3 Sterile Infusions Compounding Pharmacy Market Challenges
2.3.4 Sterile Infusions Compounding Pharmacy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sterile Infusions Compounding Pharmacy Players by Revenue
3.1.1 Global Top Sterile Infusions Compounding Pharmacy Players by Revenue (2020-2025)
3.1.2 Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Players (2020-2025)
3.2 Global Sterile Infusions Compounding Pharmacy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sterile Infusions Compounding Pharmacy Revenue
3.4 Global Sterile Infusions Compounding Pharmacy Market Concentration Ratio
3.4.1 Global Sterile Infusions Compounding Pharmacy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sterile Infusions Compounding Pharmacy Revenue in 2024
3.5 Global Key Players of Sterile Infusions Compounding Pharmacy Head office and Area Served
3.6 Global Key Players of Sterile Infusions Compounding Pharmacy, Product and Application
3.7 Global Key Players of Sterile Infusions Compounding Pharmacy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sterile Infusions Compounding Pharmacy Breakdown Data by Type
4.1 Global Sterile Infusions Compounding Pharmacy Historic Market Size by Type (2020-2025)
4.2 Global Sterile Infusions Compounding Pharmacy Forecasted Market Size by Type (2026-2031)
5 Sterile Infusions Compounding Pharmacy Breakdown Data by Application
5.1 Global Sterile Infusions Compounding Pharmacy Historic Market Size by Application (2020-2025)
5.2 Global Sterile Infusions Compounding Pharmacy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sterile Infusions Compounding Pharmacy Market Size (2020-2031)
6.2 North America Sterile Infusions Compounding Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sterile Infusions Compounding Pharmacy Market Size by Country (2020-2025)
6.4 North America Sterile Infusions Compounding Pharmacy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sterile Infusions Compounding Pharmacy Market Size (2020-2031)
7.2 Europe Sterile Infusions Compounding Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sterile Infusions Compounding Pharmacy Market Size by Country (2020-2025)
7.4 Europe Sterile Infusions Compounding Pharmacy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sterile Infusions Compounding Pharmacy Market Size (2020-2031)
8.2 Asia-Pacific Sterile Infusions Compounding Pharmacy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sterile Infusions Compounding Pharmacy Market Size by Region (2020-2025)
8.4 Asia-Pacific Sterile Infusions Compounding Pharmacy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sterile Infusions Compounding Pharmacy Market Size (2020-2031)
9.2 Latin America Sterile Infusions Compounding Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sterile Infusions Compounding Pharmacy Market Size by Country (2020-2025)
9.4 Latin America Sterile Infusions Compounding Pharmacy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size (2020-2031)
10.2 Middle East & Africa Sterile Infusions Compounding Pharmacy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Country (2020-2025)
10.4 Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Details
11.1.2 Baxter Business Overview
11.1.3 Baxter Sterile Infusions Compounding Pharmacy Introduction
11.1.4 Baxter Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.1.5 Baxter Recent Development
11.2 B. Braun
11.2.1 B. Braun Company Details
11.2.2 B. Braun Business Overview
11.2.3 B. Braun Sterile Infusions Compounding Pharmacy Introduction
11.2.4 B. Braun Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.2.5 B. Braun Recent Development
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Details
11.3.2 Fresenius Kabi Business Overview
11.3.3 Fresenius Kabi Sterile Infusions Compounding Pharmacy Introduction
11.3.4 Fresenius Kabi Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.3.5 Fresenius Kabi Recent Development
11.4 Kelun Pharma
11.4.1 Kelun Pharma Company Details
11.4.2 Kelun Pharma Business Overview
11.4.3 Kelun Pharma Sterile Infusions Compounding Pharmacy Introduction
11.4.4 Kelun Pharma Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.4.5 Kelun Pharma Recent Development
11.5 Otsuka Pharmaceutical
11.5.1 Otsuka Pharmaceutical Company Details
11.5.2 Otsuka Pharmaceutical Business Overview
11.5.3 Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Introduction
11.5.4 Otsuka Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.5.5 Otsuka Pharmaceutical Recent Development
11.6 JW Pharmaceutical
11.6.1 JW Pharmaceutical Company Details
11.6.2 JW Pharmaceutical Business Overview
11.6.3 JW Pharmaceutical Sterile Infusions Compounding Pharmacy Introduction
11.6.4 JW Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.6.5 JW Pharmaceutical Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Sterile Infusions Compounding Pharmacy Introduction
11.7.4 Pfizer Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Introduction
11.8.4 Teva Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.8.5 Teva Pharmaceutical Recent Development
11.9 Haisco Pharmaceutical Group
11.9.1 Haisco Pharmaceutical Group Company Details
11.9.2 Haisco Pharmaceutical Group Business Overview
11.9.3 Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Introduction
11.9.4 Haisco Pharmaceutical Group Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.9.5 Haisco Pharmaceutical Group Recent Development
11.10 King York
11.10.1 King York Company Details
11.10.2 King York Business Overview
11.10.3 King York Sterile Infusions Compounding Pharmacy Introduction
11.10.4 King York Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.10.5 King York Recent Development
11.11 Cisen
11.11.1 Cisen Company Details
11.11.2 Cisen Business Overview
11.11.3 Cisen Sterile Infusions Compounding Pharmacy Introduction
11.11.4 Cisen Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.11.5 Cisen Recent Development
11.12 Lummy
11.12.1 Lummy Company Details
11.12.2 Lummy Business Overview
11.12.3 Lummy Sterile Infusions Compounding Pharmacy Introduction
11.12.4 Lummy Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.12.5 Lummy Recent Development
11.13 Grand Life Sciences
11.13.1 Grand Life Sciences Company Details
11.13.2 Grand Life Sciences Business Overview
11.13.3 Grand Life Sciences Sterile Infusions Compounding Pharmacy Introduction
11.13.4 Grand Life Sciences Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.13.5 Grand Life Sciences Recent Development
11.14 Medisan
11.14.1 Medisan Company Details
11.14.2 Medisan Business Overview
11.14.3 Medisan Sterile Infusions Compounding Pharmacy Introduction
11.14.4 Medisan Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.14.5 Medisan Recent Development
11.15 BBCA Pharmaceutical
11.15.1 BBCA Pharmaceutical Company Details
11.15.2 BBCA Pharmaceutical Business Overview
11.15.3 BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Introduction
11.15.4 BBCA Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.15.5 BBCA Pharmaceutical Recent Development
11.16 Biokin Pharmaceutical
11.16.1 Biokin Pharmaceutical Company Details
11.16.2 Biokin Pharmaceutical Business Overview
11.16.3 Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Introduction
11.16.4 Biokin Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.16.5 Biokin Pharmaceutical Recent Development
11.17 Xi'an Libang Pharmaceutical
11.17.1 Xi'an Libang Pharmaceutical Company Details
11.17.2 Xi'an Libang Pharmaceutical Business Overview
11.17.3 Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Introduction
11.17.4 Xi'an Libang Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.17.5 Xi'an Libang Pharmaceutical Recent Development
11.18 Lionco Pharmaceutical
11.18.1 Lionco Pharmaceutical Company Details
11.18.2 Lionco Pharmaceutical Business Overview
11.18.3 Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Introduction
11.18.4 Lionco Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.18.5 Lionco Pharmaceutical Recent Development
11.19 China Meheco Kangli
11.19.1 China Meheco Kangli Company Details
11.19.2 China Meheco Kangli Business Overview
11.19.3 China Meheco Kangli Sterile Infusions Compounding Pharmacy Introduction
11.19.4 China Meheco Kangli Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025)
11.19.5 China Meheco Kangli Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Baxter
B. Braun
Fresenius Kabi
Kelun Pharma
Otsuka Pharmaceutical
JW Pharmaceutical
Pfizer Inc
Teva Pharmaceutical
Haisco Pharmaceutical Group
King York
Cisen
Lummy
Grand Life Sciences
Medisan
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi'an Libang Pharmaceutical
Lionco Pharmaceutical
China Meheco Kangli
List of Tables
 Table 1. Global Sterile Infusions Compounding Pharmacy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Anti-infectives
 Table 3. Key Players of Blood Factors
 Table 4. Key Players of Immunotherapies
 Table 5. Key Players of Others
 Table 6. Global Sterile Infusions Compounding Pharmacy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Sterile Infusions Compounding Pharmacy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Sterile Infusions Compounding Pharmacy Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Sterile Infusions Compounding Pharmacy Market Share by Region (2020-2025)
 Table 10. Global Sterile Infusions Compounding Pharmacy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Sterile Infusions Compounding Pharmacy Market Share by Region (2026-2031)
 Table 12. Sterile Infusions Compounding Pharmacy Market Trends
 Table 13. Sterile Infusions Compounding Pharmacy Market Drivers
 Table 14. Sterile Infusions Compounding Pharmacy Market Challenges
 Table 15. Sterile Infusions Compounding Pharmacy Market Restraints
 Table 16. Global Sterile Infusions Compounding Pharmacy Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Sterile Infusions Compounding Pharmacy Market Share by Players (2020-2025)
 Table 18. Global Top Sterile Infusions Compounding Pharmacy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Infusions Compounding Pharmacy as of 2024)
 Table 19. Ranking of Global Top Sterile Infusions Compounding Pharmacy Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Sterile Infusions Compounding Pharmacy Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Sterile Infusions Compounding Pharmacy, Headquarters and Area Served
 Table 22. Global Key Players of Sterile Infusions Compounding Pharmacy, Product and Application
 Table 23. Global Key Players of Sterile Infusions Compounding Pharmacy, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Sterile Infusions Compounding Pharmacy Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Type (2020-2025)
 Table 27. Global Sterile Infusions Compounding Pharmacy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Type (2026-2031)
 Table 29. Global Sterile Infusions Compounding Pharmacy Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Application (2020-2025)
 Table 31. Global Sterile Infusions Compounding Pharmacy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Application (2026-2031)
 Table 33. North America Sterile Infusions Compounding Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Sterile Infusions Compounding Pharmacy Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Sterile Infusions Compounding Pharmacy Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Sterile Infusions Compounding Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Sterile Infusions Compounding Pharmacy Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Sterile Infusions Compounding Pharmacy Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Sterile Infusions Compounding Pharmacy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Sterile Infusions Compounding Pharmacy Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Sterile Infusions Compounding Pharmacy Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Sterile Infusions Compounding Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Sterile Infusions Compounding Pharmacy Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Sterile Infusions Compounding Pharmacy Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Baxter Company Details
 Table 49. Baxter Business Overview
 Table 50. Baxter Sterile Infusions Compounding Pharmacy Product
 Table 51. Baxter Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 52. Baxter Recent Development
 Table 53. B. Braun Company Details
 Table 54. B. Braun Business Overview
 Table 55. B. Braun Sterile Infusions Compounding Pharmacy Product
 Table 56. B. Braun Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 57. B. Braun Recent Development
 Table 58. Fresenius Kabi Company Details
 Table 59. Fresenius Kabi Business Overview
 Table 60. Fresenius Kabi Sterile Infusions Compounding Pharmacy Product
 Table 61. Fresenius Kabi Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 62. Fresenius Kabi Recent Development
 Table 63. Kelun Pharma Company Details
 Table 64. Kelun Pharma Business Overview
 Table 65. Kelun Pharma Sterile Infusions Compounding Pharmacy Product
 Table 66. Kelun Pharma Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 67. Kelun Pharma Recent Development
 Table 68. Otsuka Pharmaceutical Company Details
 Table 69. Otsuka Pharmaceutical Business Overview
 Table 70. Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Product
 Table 71. Otsuka Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 72. Otsuka Pharmaceutical Recent Development
 Table 73. JW Pharmaceutical Company Details
 Table 74. JW Pharmaceutical Business Overview
 Table 75. JW Pharmaceutical Sterile Infusions Compounding Pharmacy Product
 Table 76. JW Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 77. JW Pharmaceutical Recent Development
 Table 78. Pfizer Company Details
 Table 79. Pfizer Business Overview
 Table 80. Pfizer Sterile Infusions Compounding Pharmacy Product
 Table 81. Pfizer Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 82. Pfizer Recent Development
 Table 83. Teva Pharmaceutical Company Details
 Table 84. Teva Pharmaceutical Business Overview
 Table 85. Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Product
 Table 86. Teva Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 87. Teva Pharmaceutical Recent Development
 Table 88. Haisco Pharmaceutical Group Company Details
 Table 89. Haisco Pharmaceutical Group Business Overview
 Table 90. Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Product
 Table 91. Haisco Pharmaceutical Group Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 92. Haisco Pharmaceutical Group Recent Development
 Table 93. King York Company Details
 Table 94. King York Business Overview
 Table 95. King York Sterile Infusions Compounding Pharmacy Product
 Table 96. King York Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 97. King York Recent Development
 Table 98. Cisen Company Details
 Table 99. Cisen Business Overview
 Table 100. Cisen Sterile Infusions Compounding Pharmacy Product
 Table 101. Cisen Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 102. Cisen Recent Development
 Table 103. Lummy Company Details
 Table 104. Lummy Business Overview
 Table 105. Lummy Sterile Infusions Compounding Pharmacy Product
 Table 106. Lummy Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 107. Lummy Recent Development
 Table 108. Grand Life Sciences Company Details
 Table 109. Grand Life Sciences Business Overview
 Table 110. Grand Life Sciences Sterile Infusions Compounding Pharmacy Product
 Table 111. Grand Life Sciences Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 112. Grand Life Sciences Recent Development
 Table 113. Medisan Company Details
 Table 114. Medisan Business Overview
 Table 115. Medisan Sterile Infusions Compounding Pharmacy Product
 Table 116. Medisan Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 117. Medisan Recent Development
 Table 118. BBCA Pharmaceutical Company Details
 Table 119. BBCA Pharmaceutical Business Overview
 Table 120. BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Product
 Table 121. BBCA Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 122. BBCA Pharmaceutical Recent Development
 Table 123. Biokin Pharmaceutical Company Details
 Table 124. Biokin Pharmaceutical Business Overview
 Table 125. Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Product
 Table 126. Biokin Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 127. Biokin Pharmaceutical Recent Development
 Table 128. Xi'an Libang Pharmaceutical Company Details
 Table 129. Xi'an Libang Pharmaceutical Business Overview
 Table 130. Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Product
 Table 131. Xi'an Libang Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 132. Xi'an Libang Pharmaceutical Recent Development
 Table 133. Lionco Pharmaceutical Company Details
 Table 134. Lionco Pharmaceutical Business Overview
 Table 135. Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Product
 Table 136. Lionco Pharmaceutical Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 137. Lionco Pharmaceutical Recent Development
 Table 138. China Meheco Kangli Company Details
 Table 139. China Meheco Kangli Business Overview
 Table 140. China Meheco Kangli Sterile Infusions Compounding Pharmacy Product
 Table 141. China Meheco Kangli Revenue in Sterile Infusions Compounding Pharmacy Business (2020-2025) & (US$ Million)
 Table 142. China Meheco Kangli Recent Development
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Sterile Infusions Compounding Pharmacy Picture
 Figure 2. Global Sterile Infusions Compounding Pharmacy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sterile Infusions Compounding Pharmacy Market Share by Type: 2024 VS 2031
 Figure 4. Anti-infectives Features
 Figure 5. Blood Factors Features
 Figure 6. Immunotherapies Features
 Figure 7. Others Features
 Figure 8. Global Sterile Infusions Compounding Pharmacy Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Sterile Infusions Compounding Pharmacy Market Share by Application: 2024 VS 2031
 Figure 10. Consumers Aged 18 and Younger Case Studies
 Figure 11. Consumers Aged 19 to 44 Case Studies
 Figure 12. Consumers Aged 45 to 64 Case Studies
 Figure 13. Consumers Aged 65 and Older Case Studies
 Figure 14. Sterile Infusions Compounding Pharmacy Report Years Considered
 Figure 15. Global Sterile Infusions Compounding Pharmacy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Sterile Infusions Compounding Pharmacy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Sterile Infusions Compounding Pharmacy Market Share by Region: 2024 VS 2031
 Figure 18. Global Sterile Infusions Compounding Pharmacy Market Share by Players in 2024
 Figure 19. Global Top Sterile Infusions Compounding Pharmacy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Infusions Compounding Pharmacy as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Sterile Infusions Compounding Pharmacy Revenue in 2024
 Figure 21. North America Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Sterile Infusions Compounding Pharmacy Market Share by Country (2020-2031)
 Figure 23. United States Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Sterile Infusions Compounding Pharmacy Market Share by Country (2020-2031)
 Figure 27. Germany Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Sterile Infusions Compounding Pharmacy Market Share by Region (2020-2031)
 Figure 35. China Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Sterile Infusions Compounding Pharmacy Market Share by Country (2020-2031)
 Figure 43. Mexico Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Share by Country (2020-2031)
 Figure 47. Turkey Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Sterile Infusions Compounding Pharmacy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Baxter Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 51. B. Braun Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 52. Fresenius Kabi Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 53. Kelun Pharma Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 54. Otsuka Pharmaceutical Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 55. JW Pharmaceutical Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 56. Pfizer Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 57. Teva Pharmaceutical Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 58. Haisco Pharmaceutical Group Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 59. King York Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 60. Cisen Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 61. Lummy Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 62. Grand Life Sciences Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 63. Medisan Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 64. BBCA Pharmaceutical Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 65. Biokin Pharmaceutical Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 66. Xi'an Libang Pharmaceutical Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 67. Lionco Pharmaceutical Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 68. China Meheco Kangli Revenue Growth Rate in Sterile Infusions Compounding Pharmacy Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Sterile Compounding Pharmacy Market Research Report 2025
Global Sterile Injections Compounding Pharmacy Market Research Report 2025
Global Compounded Sterile Preparations Pharmacy Market Research Report 2025
Global Intravenous Solution Compounder Market Research Report 2024
Global Sterile Injectable Drugs Market Research Report 2024
Sterile Injectables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sterile Injectables Production Line Market Research Report 2025
Global Sterile Disinfection Supplies Market Insights Forecast to 2030
Global Sterile Solution for Injection Market Insights Forecast to 2030
Global Sterile Packaging for Medical Market Insights Forecast to 2030
Global Pharmaceutical Sterile Injectables Market Research Report 2024
Global Small Molecule Sterile Injectable Drugs Market Research Report 2024
Sterile Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sterile Bottles Market Research Report 2024
Global Compounding Pharmacy Service Market Research Report 2025
Global Hazardous Drug Compounding Systems Market Research Report 2024
Sterile Medical Infusion Paste Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sterile Injection Development Market Research Report 2025
Global Sterile Syringes Market Research Report 2025
Global Infusion Fluid Holder Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions